Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
<h4>Background</h4>It is now well recognised that the risk of severe COVID-19 increases with some long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs and there is a lack of data on the influence of multimorbidity (≥2 LTCs) on the risk of COVID-19. Gi...
Autori principali: | , , , , , , , , , , , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Public Library of Science (PLoS)
2020-01-01
|
Serie: | PLoS ONE |
Accesso online: | https://doi.org/10.1371/journal.pone.0238091 |